[On the therapy of the combination form of Adams-Stokes syndrome with orciprenaline].
D000219:Adams-Stokes Syndrome / Q000188:drug therapy*; D000368:Aged; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004554:Electric Countershock; D005260:Female; D006801:Humans; D008614:Meperidine / Q000627:therapeutic use; D009921:Metaproterenol / Q000627:therapeutic use; D010627:Phenethylamines / Q000627:therapeutic use; D010634:Phenobarbital / Q000627:therapeutic use; D008517:Phytotherapy; D010946:Plants, Medicinal; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D011926:Rauwolfia / Q000627:therapeutic use; D012118:Resorcinols / Q000627:therapeutic use; D014693:Ventricular Fibrillation / Q000188:drug therapy*
D001993:Bronchodilator Agents; D010627:Phenethylamines; D012118:Resorcinols; D009921:Metaproterenol; D008614:Meperidine; D011802:Quinidine; D011342:Procainamide; D010634:Phenobarbital
Zur Behandlung der Kombinationsform des Adams-Stokes-Syndroms mit Orciprenalin.